SELP and breast cancer: To assess, whether the regulation pTACI particularly in patients may be due to a differential activation status between both, HD and breast cancer patients, we next determined the endogenous activation (i.e. P-Selectin/CD62P expression) of platelets which however showed comparable levels in both groups.